ReviewJournal for immunotherapy of cancer2014
High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014.
Janice P Dutcher et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
139 papers cite itlatest 60 shown
this paperpooled ittrialcites it